You just read:

Statement from Acting FDA Commissioner Adm. Brett P. Giroir, M.D., on efforts to help make development of biosimilar and interchangeable insulin products more efficient

News provided by

U.S. Food and Drug Administration

Nov 25, 2019, 11:47 ET